publication venue for
- Reference equation for maximal voluntary ventilation in children and adolescents. 55:426-432. 2020
- Physical activity and exercise-induced bronchoconstriction in Greek schoolchildren. 47:1080-1087. 2012
- Effect of closed endotracheal tube suction method, catheter size, and post-suction recruitment during high-frequency jet ventilation in an animal model. 47:749-756. 2012
- VALIDATION OF THE INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE IN ADULTS WITH CYSTIC FIBROSIS. 382-382. 2010
- THE IMPACT OF MUSCULOSKELETAL PAIN ON ADULTS WITH CF. 422-422. 2009
- Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment. 42:465-470. 2007
- Pulmonary rehabilitation following lung transplantation. 352-352. 2007
- The effects of musculoskeletal physiotherapy and massage on pain and ease of breathing in adults with cystic fibrosis. 360-360. 2007
- EVALUATION OF MUSCULOSKELETAL AND POSTURAL FUNCTION IN CYSTIC FIBROSIS USING A PHYSIOTHERAPY SCREENING TOOL 2012
- HABITUAL PHYSICAL ACTIVITY IN ADULTS WITH CYSTIC FIBROSIS 2012
- PHYSIOTHERAPY FOR CYSTIC FIBROSIS IN AUSTRALIA: KNOWLEDGE AND ACCEPTANCE OF THE CONSENSUS STATEMENT RECOMMENDATIONS 2011
- Prevalence and impact of incontinence in adult men with cystic fibrosis 2011
- DESATURATION ON 3-MINUTE STEP TEST IS ASSOCIATED WITH IMPAIRED OUTCOMES AT 12 MONTHS IN ADULTS WITH CF 2009
- EXPIRATORY DURATION AND PRESSURE PROPERTIES OF COMMONLY USED AIRWAY CLEARANCE DEVICES WHEN USED UNSUPERVISED BY ADULTS WITH CYSTIC FIBROSIS 2019
- PATTERNS OF CHANGE IN BODY COMPOSITION ON TREATMENT WITH LUMACAFTOR-IVACAFTOR IN SEVERE CYSTIC FIBROSIS LUNG DISEASE: EARLY GAINS IN WEIGHT AND FAT MASS PLATEAU BY ONE YEAR 2018
- POSITIVE EXPIRATORY PRESSURE THERAPY RECORDER FOR ASSESSING COMPLIANCE: A NEW DEVICE FOR CLINICAL PRACTICE AND RESEARCH 2018
- IMPACT OF LUMACAFTOR-IVACAFTOR ON BODY COMPOSITION IN ADULTS WITH SEVERE CYSTIC FIBROSIS LUNG DISEASE 2017
- NUTRITION GUIDELINES FOR CYSTIC FIBROSIS IN AUSTRALIA AND NEW ZEALAND: DEVELOPMENT OF EVIDENCE-BASED AND CONSENSUS RECOMMENDATIONS 2017
- ORKAMBI (TM) FOR PATIENTS WITH FEV1 < 40%: SIX MONTHS' OUTCOMES INCLUDING ALFRED WELLNESS SCORE "AWESCORE," EXERCISE CAPACITY, AND LUNG FUNCTION 2017
- RELIABILITY OF THE ALFRED WELLNESS SCORE (AWESCORE) FOR USE IN ADULTS WITH CF 2017
- IVACAFTOR IMPROVES WELLNESS, QUALITY OF LIFE AND COGNITIVE FUNCTION IN G551D CYSTIC FIBROSIS 2015
- PATIENT AND PHYSIOTHERAPIST REPORTED ADHERENCE TO AIRWAY CLEARANCE THERAPY, INHALATIONS AND EXERCISE TOGETHER WITH LUNG FUNCTION OUTCOMES OVER THREE YEARS 2013
- PHYSICAL INACTIVITY PREDICTS HOSPITALIZATION IN ADULTS WITH CYSTIC FIBROSIS 2013
- Comparison of skinfolds and dual-energy X-ray absorptiometry to assess change in body composition in adults with cystic fibrosis 2007
- Renal impairment is common in the adult cystic fibrosis population and is poorly detected by serum creatinine monitoring 2007
- Serum levels of advanced glycation endproducts are elevated in cystic fibrosis 2007